TriangleNCT00481871 · MORE INFO
Limitations, agreements, and source contact
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- certain Agreement
- other Details
- Allos agreements with investigators (PIs) may vary. The PI may publish/make public data from the trial after the earlier of publication by Allos or 18 months after study completion. Allos can review results communications prior to public release and can embargo communications regarding trial results for a period less than or equal to 90 days from submission for review. Allos can request changes to the communication related to confidential or patent information, or to ensure accuracy.
- pi Sponsor Employee
- false
- restriction Type
- OTHER
- restrictive Agreement
- true
- point Of Contact
- msaunders@allos.com
- organization
- Allos Therapeutics, Inc.
- phone
- 303-426-6262
- title
- Michael Saunders, MD
Complete source fields
- certain Agreement
- other Details
- Allos agreements with investigators (PIs) may vary. The PI may publish/make public data from the trial after the earlier of publication by Allos or 18 months after study completion. Allos can review results communications prior to public release and can embargo communications regarding trial results for a period less than or equal to 90 days from submission for review. Allos can request changes to the communication related to confidential or patent information, or to ensure accuracy.
- pi Sponsor Employee
- false
- restriction Type
- OTHER
- restrictive Agreement
- true
- point Of Contact
- msaunders@allos.com
- organization
- Allos Therapeutics, Inc.
- phone
- 303-426-6262
- title
- Michael Saunders, MD
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice